These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35462338)

  • 1. CXCL12 inhibits hair growth through CXCR4.
    Zheng M; Oh SH; Choi N; Choi YJ; Kim J; Sung JH
    Biomed Pharmacother; 2022 Jun; 150():112996. PubMed ID: 35462338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata.
    Zheng M; Kim MH; Park SG; Kim WS; Oh SH; Sung JH
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT5 Activation in the Dermal Papilla Is Important for Hair Follicle Growth Phase Induction.
    Legrand JMD; Roy E; Ellis JJ; Francois M; Brooks AJ; Khosrotehrani K
    J Invest Dermatol; 2016 Sep; 136(9):1781-1791. PubMed ID: 27131881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor signalling in the hair growth cycle: expression of the fibroblast growth factor receptor and ligand genes in the murine hair follicle.
    Rosenquist TA; Martin GR
    Dev Dyn; 1996 Apr; 205(4):379-86. PubMed ID: 8901049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HNG, A Humanin Analogue, Promotes Hair Growth by Inhibiting Anagen-to-Catagen Transition.
    Kim SM; Kang JI; Yoon HS; Choi YK; Go JS; Oh SK; Ahn M; Kim J; Koh YS; Hyun JW; Yoo ES; Kang HK
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of FGF and FGFR expression in skin: FGF18 is highly expressed in hair follicles and capable of inducing anagen from telogen stage hair follicles.
    Kawano M; Komi-Kuramochi A; Asada M; Suzuki M; Oki J; Jiang J; Imamura T
    J Invest Dermatol; 2005 May; 124(5):877-85. PubMed ID: 15854025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and location of phospho-Artemis (Serine516) in hair follicles during induced growth of mouse hair.
    Wu XJ; Zhu JW; Liu H; Lu ZF; Zheng M
    Arch Dermatol Res; 2012 May; 304(4):319-24. PubMed ID: 22476261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1 is strongly expressed in the anagen hair follicle outer root sheath and in the dermal papilla but expression diminishes with involution of the hair follicle.
    Bayer-Garner IB; Sanderson RD; Smoller BR
    Am J Dermatopathol; 2002 Dec; 24(6):484-9. PubMed ID: 12454600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of Wnt5a during the hair cycle and its role in hair shaft growth in mice.
    Xing Y; Xu W; Yang K; Lian X; Yang T
    Acta Histochem; 2011 Oct; 113(6):608-12. PubMed ID: 20656336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygonum multiflorum extract support hair growth by elongating anagen phase and abrogating the effect of androgen in cultured human dermal papilla cells.
    Shin JY; Choi YH; Kim J; Park SY; Nam YJ; Lee SY; Jeon JH; Jin MH; Lee S
    BMC Complement Med Ther; 2020 May; 20(1):144. PubMed ID: 32398000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine SDF-1/CXCL12 regulates the migration of melanocyte progenitors in mouse hair follicles.
    Belmadani A; Jung H; Ren D; Miller RJ
    Differentiation; 2009 Apr; 77(4):395-411. PubMed ID: 19281787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
    Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
    Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.
    Boudot A; Kerdivel G; Habauzit D; Eeckhoute J; Le Dily F; Flouriot G; Samson M; Pakdel F
    PLoS One; 2011; 6(6):e20898. PubMed ID: 21695171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
    Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
    Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.
    Shen HB; Gu ZQ; Jian K; Qi J
    Tumour Biol; 2013 Jun; 34(3):1839-45. PubMed ID: 23526079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia improves hair inductivity of dermal papilla cells via nuclear NADPH oxidase 4-mediated reactive oxygen species generation'.
    Zheng M; Jang Y; Choi N; Kim DY; Han TW; Yeo JH; Lee J; Sung JH
    Br J Dermatol; 2019 Sep; 181(3):523-534. PubMed ID: 30703252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12/CXCR4 axis triggers the activation of EGF receptor and ERK signaling pathway in CsA-induced proliferation of human trophoblast cells.
    Zhao HB; Tang CL; Hou YL; Xue LR; Li MQ; Du MR; Li DJ
    PLoS One; 2012; 7(7):e38375. PubMed ID: 22848341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.